Merit Financial Group LLC Boosts Stake in Merck & Co., Inc.

Merk & Co., Inc.'s shares were purchased by Merit Financial Group LLC in the second quarter, increasing their holdings in the company by 6.3%. The fund now owns 209,288 shares of Merck's stock, worth $26,893,000 as of its most recent SEC filing.

This is not an isolated instance, as several other institutional investors and hedge funds have also modified their holdings in Merck & Co., Inc. during the second quarter. Kavar Capital Partners Group LLC increased its position in shares by 1.0%, while Financial Advisory Partners LLC boosted its holdings by 0.7%. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors grew its position by 2.2%, and Palisade Asset Management LLC increased its stake by 0.6%.

Merk & Co., Inc.'s stock has been reaching new highs, with a recent all-time high of $135.68. Analysts have upgraded the company's rating to 'outperform' and set price targets in the range of $140, $155. The company's late-stage pipeline, business-development efforts, and continued demand for Keytruda are seen as supporting growth.

However, some analysts have raised concerns about Merck's reliance on Keytruda and the potential impact of patent loss and increasing competition on sales and earnings. Despite this, the company has reported revenue of $16.61 billion in its most recent quarter, exceeding expectations.